Organon & Co. Short Interest Rises 21.9% in February

Got story updates? Submit your updates here. ›

Organon & Co. (NYSE:OGN), a global healthcare company focused on women's health, biosimilars, and established brands, saw a significant increase in short interest during February 2026. As of February 13th, short interest totaled 17,545,543 shares, up 21.9% from the January 29th total of 14,393,046 shares. This represents approximately 6.8% of the company's outstanding shares.

Why it matters

The rise in short interest suggests that some investors are betting against Organon's stock performance, potentially indicating concerns about the company's outlook or operations. Short selling activity can impact a stock's price and volatility, so the increase is noteworthy for Organon and its investors.

The details

According to the report, the days-to-cover ratio, which measures the number of days it would take short sellers to cover their positions based on average daily trading volume, is currently 3.3 days. This indicates that it would take short sellers just over 3 days to cover their positions if they wanted to exit their bets against the stock.

• As of February 13th, 2026, Organon & Co. had short interest totaling 17,545,543 shares.
• This represents a 21.9% increase from the January 29th, 2026 short interest total of 14,393,046 shares.